spoke manag four post conf-cal
thought feedback result
headlin ep perspect bull us
look -- ye market environ particularli reward
stock right miss -- peel back fundament onion
number suggest short-term print realli chang thesi
turn-around stori particularli conserv management reiter guidanc
suggest like track
ye mix result littl bit bull bear reiter think
probabl bounc admit stock first investor like
see miss partli inventori issu hiv spoke compani
believ emphas see -- compani like market buy
stock w/ author open also get season way
histor better think stock bounc dip fundament
standpoint hiv seem fine hcv littl weaker surpris frankli move
baffl downsid speak investor sentiment larg cap need
short-term thesi
bear domin convers basic point hiv miss miss
specif quantifi drawdown hcv miss take share
bottom hcv miss generalist want see still
reiter hcv guidanc whether good thing overhang yee bull thesi
turn-around clear today result -- need prove
conf call co note
said hiv inventori magnitud chang larger past
miss estimate vs con also rev
viread gener report vs con ran number w/ management
commentari suggest inventori drawdown key culprit script grew yy
despit hiv rev yy last year simpl math say around
inventori impact view inventori drawdown due gener viread
us hbv use less need older hiv regimen due ramp biktarvi biktarvi
half inventori stock said launch in-lin w/ expect
week revenu eighti percent come switch regimen
genvoya gsk regimen
said still think hcv rang prior guidanc hcv
miss competit environ stiff ou still reiter gener impli hcv
guidanc slide slide part overal product revenu
acknowledg print impli probabl low end guidanc
view management emphas big step price got adjust
new contract hit taken modest declin --
target zone think w/ guidanc
said think trough year grow base similar
said take hiv hcv yescarta think hcv stabil
growth year
kite yescarta beat posit commentari get specif management
said earli day go get detail center comfort
launch date pleas revenu reimburs alreadi
rel confid nash pipelin despit easl investor feedback
nash combo mix data see prior note short
studi investor look good indic need placebo longer mo
studi biopsi differ interpret base reader news
phase nash data consensu mostli free call option
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
gilead leader develop market anti-infect drug approv product treatment hiv/aid hep
 hepat liver pulmonolog diseas gilead develop pipelin antivir liver diseas immunolog oncolog
compani extens world-wide sale market infrastructur
michael yee certifi view express research report accur reflect person view subject secur
subject compani also certifi part compens directli indirectli relat specif recommend
view express research report
andrew tsai certifi view express research report accur reflect person view subject secur
subject compani also certifi part compens directli indirectli relat specif recommend
view express research report
kelechi chiker ph certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat specif
recommend view express research report
arshad haider certifi view express research report accur reflect person view subject secur
subject compani also certifi part compens directli indirectli relat specif recommend
view express research report
case jefferi employe analyst respons coverag financi instrument discuss report receiv
compens base part overal perform firm includ invest bank incom seek updat research
appropri variou regul may prevent us asid certain industri report publish period basi larg major
report publish irregular interv appropri analyst judgement
articl articl
jefferi llc act financi advisor kite pharma kite sale compani
steven desancti own share inc common share
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr glaxosmithklin plc
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within period
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate secur averag
secur price consist expect total return price appreci plu yield plu minu within period
under-perform rate secur averag secur price consist expect total return price appreci plu yield minu
less within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/
jefferi polici
cs coverag suspend jefferi suspend coverag compani
nc cover jefferi cover compani
restrict describ issuer conjunct jefferi engag certain transact compani polici applic secur
regul prohibit certain type commun includ invest recommend
monitor describ secur whose compani fundament financi monitor financi project opinion
invest merit compani provid
jefferi methodolog assign rate may includ follow market capit matur growth/valu volatil expect total
return next month price target base sever methodolog may includ restrict analys market
page
pleas see import disclosur inform page report
p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
jefferi franchis pick includ stock select among best stock idea equiti analyst month period stock select
base fundament analysi may take account factor analyst convict differenti analysi favor risk/reward
ratio invest theme jefferi analyst recommend jefferi franchis pick includ buy rate stock number
vari depend analyst recommend inclus stock ad new opportun aris remov reason
inclus chang stock met desir return longer rate buy and/or trigger stop loss stock day volatil
bottom quartil stock continu stop loss remaind stop franchis pick intend
repres recommend portfolio stock sector base may note believ pick fall within invest style
growth valu
risk may imped achiev price target
report prepar gener circul provid invest recommend specif individu investor
financi instrument discuss report may suitabl investor investor must make invest decis base
upon specif invest object financi situat util financi advisor deem necessari past perform
financi instrument recommend report taken indic guarante futur result price valu
incom financi instrument mention report rise well fall may affect chang econom financi
polit factor financi instrument denomin currenc investor home currenc chang exchang rate may
advers affect price valu incom deriv financi instrument describ report addit investor secur
adr whose valu affect currenc underli secur effect assum currenc risk
compani mention report
page
pleas see import disclosur inform page report
